Don't Let Your Filling Equipment Dictate Your Drug Formulation

By Chris Webster

In early-stage pharmaceutical development, poor powder flow is often a consequence of optimizing compounds for maximum solubility and bioavailability. Micronization and spray drying alter particle morphology to enhance dissolution, but they create cohesive powders that resist traditional volumetric filling. Forcing these challenging formulations into standard equipment frequently leads to premature, costly reformulations that delay clinical entry and risk altering drug performance.

3P innovation’s Fill2Weight platform offers a direct solution by replacing volumetric dosing with high-precision gravimetric filling. Dosing by true mass rather than predictable powder flow gives formulation scientists the freedom to prioritize patient outcomes over manufacturing limitations. By eliminating equipment-driven reformulation, development teams can preserve early pharmacokinetic designs, accelerate clinical phase transitions, and scale seamlessly from R&D to commercial production. Explore how gravimetric dosing streamlines early-phase development.